ABEONA THERAPEUTICS INC. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (18 lists). Names and jurisdictions are as filed.
- 2026-03-17: Subsidiary Abeona.
- 2026-03-17: Subsidiary Therapeutics LLC, an Ohio company.
- 2026-03-17: Subsidiary MacroChem.
- 2026-03-17: Subsidiary Corporation, a Delaware company.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-17 | Abeona | |
| 2026-03-17 | Therapeutics LLC, an Ohio company | |
| 2026-03-17 | MacroChem | |
| 2026-03-17 | Corporation, a Delaware company |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |